The Future of Idiopathic Inflammatory Myositis: Market Insights and Emerging Therapies through 2034 The idiopathic inflammatory myositis market is projected to achieve remarkable growth due to emerging therapies and increasing prevalence of the disease.

The Future of Idiopathic Inflammatory Myositis: Market Insights and Emerging Therapies through 2034 #None #Myositis #Dazukibart #Efgartigimod